Ryman Healthcare (RYM) Investor Day 2026 summary
Event summary combining transcript, slides, and related documents.
Investor Day 2026 summary
8 Jul, 2026Refreshed strategy and leadership
Shift from rapid development-led growth to a focus on sustainable, recurring earnings, leveraging a high-quality, integrated retirement living and care portfolio.
New management team and independent board with deep sector and transformation experience to execute the refreshed strategy and provide long-term strategic oversight.
Strategy pillars include care-centric living for the 80+ market, recurring earnings growth, portfolio optimization, and value-creating growth.
Emphasis on operational excellence, optimizing a NZD 12 billion property portfolio, and disciplined capital allocation.
Reset of revenue, balance sheet, and financial transparency, with positive free cash flow delivered for the first time in over a decade.
Financial targets and capital management
Targeting NZD 150 million in sustainable cash flow improvement by FY 2029, at the top end of the previous range.
Aiming for at least NZD 500 million in cash release by FY 2029, including NZD 800 million from new and paid-out resale stock and NZD 200 million from land sales.
New capital management framework with a 20%-30% gearing target and a dividend payout policy of 20%-50% of CFEO, resuming from FY 2028.
Retirement living segment targets a >5% yield; aged care targets EBITDAF per bed of NZD 25,000–NZD 30,000 by FY 2029.
Disciplined project IRR and positive NPV required for new investments, with a focus on brownfield expansion in NZ and greenfield in Australia.
Operational excellence and portfolio initiatives
High-quality clinical care, resident experience, and workforce engagement are central to operational excellence.
Sales effectiveness program underway to reduce vacant stock, improve conversion rates, and accelerate cash release.
Cost efficiency initiatives targeting NZD 50 million–NZD 60 million in annualized savings by FY 2026 through support function efficiencies and procurement.
Resident Fund launched to enable seamless transition from independent living to care, retaining capital and reducing interest costs.
Portfolio optimization includes pausing or phasing development, prioritizing brownfield expansion, and divesting non-core land for at least NZD 200 million.
Latest events from Ryman Healthcare
- Operational reset, cost savings, and equity raise drive improved cash flow despite net loss.RYM
H2 20259 Jul 2026 - Strong cash flow, cost discipline, and sustainability drive improved performance and outlook.RYM
Corporate presentation11 Jun 2026 - Secured 6-year bond offer supports refinancing and growth, leveraging strong financials.RYM
Investor presentation8 Jun 2026 - Net profit halved to $94.4M as costs rose and cash flow guidance turned negative.RYM
H1 202526 May 2026 - First positive free cash flow in a decade, higher revenue, and raised FY26 guidance amid sector reforms.RYM
H1 202626 May 2026 - Operating EBITDAF nearly doubled and free cash flow turned positive, supporting strategic progress.RYM
H2 202626 May 2026 - $1.0b equity raise reduces debt and enables transformation, targeting sustainable growth.RYM
Investor presentation14 May 2026 - Strategic reset, board overhaul, and $1B equity raise drive focus on value recovery.RYM
AGM 20253 Feb 2026 - Cash flow up, profit down, dividends suspended, new villages opened, sector funding tight.RYM
AGM 20242 Feb 2026